2020 연구자 정보 (13 / 991)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Qin, Shukui (Qin, SK) |
Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China |
|
|
[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) [JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma |
SCIE | 1.5 |
ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
aalsina@tgmg.org | ||
|
Ren, Min (Ren, M) |
Eisai Inc, Woodcliff Lake, NJ USA |
|
|
[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) [JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma |
SCIE | 1.5 |
ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
aalsina@tgmg.org | ||
|
Ryoo, Baek-Yeol (Ryoo, BY) |
Asan Med Ctr, Dept Oncol, Seoul, South Korea Univ Ulsan, Coll Med, Seoul, South Korea |
|
|
[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) [JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma |
SCIE | 1.5 |
ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
aalsina@tgmg.org | ||
|
Shimura, Tadanobu (Shimura, T) |
|
|
[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients | SCIE | 1.5 | ONCOLOGY | ||||
|
Sohn, Sang Kyun (Sohn, SK) |
교신저자 |
Kyungpook Natl Univ, Dept Hematol Oncol, Kyungpook Natl Univ Hosp, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ Hosp, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu 41944, South Korea Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea |
|
|
Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma [JCR상위 1.5%] Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma. [JCR상위 22.0%] Favorable Long-term Outcomes with Autologous Stem Cell Transplantation for High Risk Patients with Multiple Myeloma Who are Positive at FDG-PET/CT [JCR상위 80.4%] Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma [JCR상위 29.3%] COVID-19 transmission and blood transfusion: A case report [JCR상위 65.1%] Hypomethylating agent-based post-transplant strategies to maximize the outcome of high-risk acute myeloid leukemia after allogeneic stem cell transplantation [JCR상위 22.9%] RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia [JCR상위 79.6%] Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials [JCR상위 53.3%] Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial [JCR상위 50.7%] Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis |
ESCI SCIE |
1.5 |
HEMATOLOGY ONCOLOGY IMMUNOLOGY TRANSPLANTATION MEDICINE, RESEARCH & EXPERIMENTAL INFECTIOUS DISEASES PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH MULTIDISCIPLINARY SCIENCES |
jhmoon@knu.ac.kr drydh1685@hotmail.com baekdw83@gmail.com sksohn@knu.ac.kr hjoonk@chonnam.ac.kr zhaolei.zhang@utoronto.ca dr.dennis.kim@uhn.ca kimhawkmd@gmail.com drjejung@chonnam.ac.kr HEMAKIM@yuhs.ac |
|
|
Toiyama, Yuji (Toiyama, Y) |
|
|
[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients | SCIE | 1.5 | ONCOLOGY | ||||
|
Vogel, Arndt (Vogel, A) |
Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany |
A-8437-2012 Vogel, Arndt |
0000-0003-0560-5538 Vogel, Arndt |
[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) [JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma |
SCIE | 1.5 |
ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
aalsina@tgmg.org | ||
|
Yasuda, Hiromi (Yasuda, H) |
|
|
[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients | SCIE | 1.5 | ONCOLOGY | ||||
|
Yokoe, Takeshi (Yokoe, T) |
|
|
[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients | SCIE | 1.5 | ONCOLOGY | ||||
|
Abdelmalek, Manal (Abdelmalek, M) |
Duke Univ, Durham, NC 27706 USA |
AAW-2203-2020 Abdelmalek, Manal |
|
[JCR상위 1.6%] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials | SCIE | 1.6 | GASTROENTEROLOGY & HEPATOLOGY | marianne.camargo2@gilead.com | ||
|
Ahn, Sang Hoon (Ahn, SH) |
교신저자 |
Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Seoul, South Korea Yongsei Univ, Severance Hosp, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea Yonsei Univ, Severance Hosp, Coll Med, Seoul, South Korea |
AFM-2603-2022 Ahn, Sang Hoon |
0000-0002-3629-4624 Ahn, Sang Hoon |
[JCR상위 1.6%] Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea [JCR상위 8.2%] Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy [JCR상위 21.9%] Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study [JCR상위 43.6%] A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy [JCR상위 24.5%] Entecavir plus tenofovir vs. lamivudine/telbivudine plus adefovir in chronic hepatitis B patients with prior suboptimal response [JCR상위 4.5%] Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase [JCR상위 4.9%] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study [JCR상위 9.2%] Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial [JCR상위 1.6%] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results [JCR상위 25.5%] Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) [JCR상위 6.0%] APCOLIS SCORE PREDICTS OUTCOME IN PATIENTS OF CIRRHOSIS WITH SARS-COV-2 INFECTION- DATA FROM ONGOING APASL COVID LIVER INJURY SPECTRUM (APCOLIS-I) STUDY |
SCIE | 1.6 |
GASTROENTEROLOGY & HEPATOLOGY ONCOLOGY PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH INFECTIOUS DISEASES VIROLOGY PHARMACOLOGY & PHARMACY |
powerof1004@gmail.com beomkkim@yuhs.ac psyoung0419@gmail.com jheo@pusan.ac.kr ahnsh@yuhs.ac ihkimmd@jbnu.ac.kr gudwns21@korea.ac.kr KSUKOREA@yuhs.ac pietro.lampertico@unimi.it gihankhys@yuhs.ac shivsarin@gmail.com |
|
|
Bennett, C. Frank (Bennett, CF) |
Ionis Pharmaceut Inc, Carlsbad, CA USA |
|
|
[JCR상위 1.6%] Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | SCIE | 1.6 | GASTROENTEROLOGY & HEPATOLOGY | jkwoh@ionisph.com | ||
|
Camargo, Marianne (Camargo, M) |
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA |
|
|
[JCR상위 1.6%] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials | SCIE | 1.6 | GASTROENTEROLOGY & HEPATOLOGY | marianne.camargo2@gilead.com | ||
|
Chan, Henry (Chan, H) |
Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China |
B-9636-2008 Chan, Henry |
|
[JCR상위 1.6%] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | SCIE | 1.6 | GASTROENTEROLOGY & HEPATOLOGY | pietro.lampertico@unimi.it | ||
|
Chun, Ho Soo (Chun, HS) |
Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 1.6%] Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea | SCIE | 1.6 | GASTROENTEROLOGY & HEPATOLOGY | powerof1004@gmail.com |
페이지 이동: